NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

So here is a question.

When the first CI showed signs of working, the response by several BPs was to rush competing trials into the clinic with similar mabs. And now, with supposed a much more significant advance, not a peep.

Why in the last 5 years since supposedly BP knew how big this was have they not been running their own trials with ATL-DCs? The concept is 20 years old, so patents do not block them

Sure, if this really works NWBO would be first with a product in GBM (assuming the current trial earns an approval). But BP could easily have run them down in other cancers, still can.

Sorry, I find the idea that BP is manipulating the market instead of just partnering or buying out NWBO or running their own trials a bit far fetched.